Trial intelligence / Profile preview

Kangai Injection in elderly patients with non-small cell lung cancer

ChiCTR-TRC-13003884Phase 4Completed

Sponsor
Guang'anmen Hospital
Start
Apr 2013
Countries
1
01

Overview

Phase 4, randomised, open-label trial of kangai injection in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Guang'anmen Hospital. Primary endpoints: Disease control rate, Response rate and 1 more. Started Apr 2013; status: completed.

02

Drugs

kangai injection
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on ChiCTR-TRC-13003884.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-13003884.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call